4/A//SEC Filing
te Boekhorst Paul Francis Olivier 4/A
Accession 0001437749-25-036913
CIK 0000811641other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 4:11 PM ET
Size
6.2 KB
Accession
0001437749-25-036913
Insider Transaction Report
Form 4/AAmended
te Boekhorst Paul Francis Olivier
DirectorPresident and CEO
Transactions
- Purchase
Common Stock $0.10 par value per share
2025-12-03$5.04/sh+3,598$18,152→ 7,306 total - Purchase
Common Stock $0.10 par value per share
2025-12-04$5.50/sh+2,432$13,376→ 9,738 total
Footnotes (2)
- [F1]This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
- [F2]This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.
Documents
Issuer
IMMUCELL CORP /DE/
CIK 0000811641
Entity typeother
Related Parties
1- filerCIK 0002095704
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 4:11 PM ET
- Size
- 6.2 KB